Company intelligence / Profile preview

CeQur

Horw, Luzern/Lucerne, Switzerlandmyceqursimplicity.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

CeQur’s main product, the CeQur Simplicity patch, delivers injection-free mealtime insulin via a wearable device. Clinical research shows users achieve significant improvements in glycemic control—A1C reductions averaging between 1.3% and 1.7%—and high patient satisfaction (~90% adherence improvement compared to multiple daily injections). The FDA recently cleared an extended wear version of the patch for up to four days.[2][3][4][5][7] Over 6,000 patients are currently using the device as of early 2025.[7] Real-world studies show A1C reduction by an average of ~1.29–1.7%, with >94% patient satisfaction.[3]

Therapeutic areas: Endocrinology
Modalities: Drug delivery device (wearable insulin patch for rapid/bolus insulin)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

CeQur Simplicity

Commercial

Indications: Type 1 diabetes, Type 2 diabetes

Partnerships

Tandem Diabetes Care

Beyond the preview

Go deeper on CeQur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CeQur.

Explore the full profile